Patents Assigned to Whatehead Institute for Biomedical Research
  • Publication number: 20150284356
    Abstract: The present invention provides compounds of Formula I, pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting fungal or parasitic growth. The compounds are useful as inhibitors of glycosylphosphatidylinositol (GPI)-anchor biosynthesis, in particular, as inhibitors of fungal Gwt1 activity. The present invention further provides methods of using the compounds described herein for treating fungal or parasitic infections. The compounds can also be used as biological probes to study the effects of inhibiting Gwt1 activity.
    Type: Application
    Filed: June 21, 2013
    Publication date: October 8, 2015
    Applicants: Whatehead Institute for Biomedical Research, The General Hospital Corporation d/b/a Massachusetts General Hospital
    Inventors: Catherine McLellan, Ralph Mazitschek, Luke Whitesell, Susan L. Lindquist